| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $222,864,952 ) (Continued on the next page) |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01DK142682 | Autophagy, injury, and plasticity in the intestinal regenerative process | 000 | 1 | NIH | 9/8/2025 | $836,942 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R50CA305079 | Rare Tumor Clinical Research Specialist | 000 | 1 | NIH | 9/8/2025 | $197,518 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | F32DE035372 | Microfracture-based Repair for Temporomandibular Joint Osteoarthritis | 000 | 1 | NIH | 7/22/2025 | $78,840 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | K08HL173625 | Air pollution sensitivity in pediatric asthma | 000 | 1 | NIH | 8/7/2025 | $135,000 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01HL180443 | Origins of neonatal lung myofibroblasts | 001 | 1 | NIH | 8/12/2025 | -$594,583 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01HL180443 | Origins of neonatal lung myofibroblasts | 001 | 1 | NIH | 8/12/2025 | $594,583 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | K23NS140491 | Outcome measures and quantitative EEG biomarkers in SYNGAP1-related disorders | 000 | 1 | NIH | 7/31/2025 | $220,050 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01HL180443 | Origins of neonatal lung myofibroblasts | 000 | 1 | NIH | 8/5/2025 | $594,583 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | OT2OD037960 | Multimodal machine learning for diagnosis and mechanistic phenotyping of inherited diseases | 000 | 1 | NIH | 6/6/2025 | $1,156,956 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01CA237562 | Elucidating the role of the noncoding genome in neuroblastoma | 000 | 5 | NIH | 3/14/2025 | $362,340 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01CA237562 | Elucidating the role of the noncoding genome in neuroblastoma | 001 | 5 | NIH | 5/21/2025 | $40,260 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | F32DK145002 | Using real world evidence to address gaps in the use of estrogen and progesterone therapy in adolescents and premenopausal women with chronic kidney disease | 001 | 1 | NIH | 7/24/2025 | $0 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01HL177014 | Endothelial cell targeting of factor VIII for hemophilia A | 000 | 1 | NIH | 7/29/2025 | $888,836 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | F32DK145002 | Using real world evidence to address gaps in the use of estrogen and progesterone therapy in adolescents and premenopausal women with chronic kidney disease | 000 | 1 | NIH | 7/24/2025 | $93,664 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R03HD119150 | Optimizing Usability, Generalizability, and Impact of CAPNET Multicenter Child Abuse Research Network Data | 000 | 1 | NIH | 7/29/2025 | $178,000 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AR061758 | Pathogenic Mechanisms in Hereditary Multiple Exostoses Syndrome | 000 | 14 | NIH | 3/14/2025 | $348,480 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01CA258524 | Tracking Peripheral T-Cell Repertoire Changes for Preoperative and Early Ovarian Cancer Diagnosis | 001 | 5 | NIH | 5/22/2025 | $83,785 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01CA258524 | Tracking Peripheral T-Cell Repertoire Changes for Preoperative and Early Ovarian Cancer Diagnosis | 000 | 5 | NIH | 2/12/2025 | $754,071 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | P01CA217959 | Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance | 002 | 7 | NIH | 9/23/2025 | $244,722 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | P01CA217959 | Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance | 001 | 7 | NIH | 3/28/2025 | $2,202,503 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AR061758 | Pathogenic Mechanisms in Hereditary Multiple Exostoses Syndrome | 001 | 14 | NIH | 5/19/2025 | $27,104 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R25HD118212 | PARTNERS: Program to Advance Research and Transdisciplinary TraiNing in the CarE of PeRsons with Down Syndrome | 001 | 1 | NIH | 8/13/2025 | -$1,188,561 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R25HD118212 | PARTNERS: Program to Advance Research and Transdisciplinary TraiNing in the CarE of PeRsons with Down Syndrome | 000 | 1 | NIH | 8/1/2025 | $1,921,102 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | K08NS140553 | Defining JNK-associated neurodevelopmental disorders | 000 | 1 | NIH | 7/29/2025 | $221,400 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AI187174 | Defining the role of enterococci in reshaping Clostridioides difficile infection | 000 | 1 | NIH | 7/25/2025 | $812,200 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | DP2AI192737 | Decoding multidrug-resistant pathogen dynamics for clinically-relevant wastewater surveillance | 000 | 1 | NIH | 7/23/2025 | $534,000 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | K23HD119271 | Transplacental Antibiotic Exposures in Newborn Infants | 000 | 1 | NIH | 7/30/2025 | $160,056 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01HD114705 | Comprehensive identification and functional study of Esrp-regulated isoforms during epithelial-mesenchymal transition. | 000 | 1 | NIH | 3/12/2025 | $763,886 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01CA248501 | Mechanistic biomarkers to enable Bcl2 inhibitor therapies for neuroblastoma | 001 | 5 | NIH | 5/22/2025 | $39,500 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01CA248501 | Mechanistic biomarkers to enable Bcl2 inhibitor therapies for neuroblastoma | 000 | 5 | NIH | 2/13/2025 | $355,506 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | DP1DA063517 | Lifespan effects of prenatal and perinatal opioid exposure on the brain's metabolic-epigenetic axis | 000 | 1 | NIH | 8/21/2025 | $534,000 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R00HL177827 | Determining genetic mechanisms that drive in vitro hematopoiesis | 000 | 1 | NIH | 7/15/2025 | $445,000 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01HL160748 | Preserving Genome Integrity In AAV-Mediated Gene Therapy | 000 | 4 | NIH | 2/28/2025 | $580,716 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AR083245 | FGFR3 Activities in the Control of Skeletal Growth | 001 | 2 | NIH | 5/7/2025 | $50,279 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01HL179221 | Proteolytic Regulation of Factor VIII Before and After Activation | 000 | 1 | NIH | 8/13/2025 | $636,982 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AR083245 | FGFR3 Activities in the Control of Skeletal Growth | 000 | 2 | NIH | 3/5/2025 | $646,442 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R33HL171110 | Home-Based, Digital Intervention to Increase Physical Activity in Patients with the Fontan Circulation | 000 | 2 | NIH | 8/20/2025 | $1,170,016 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | K08AI193172 | From inhibitors to enzymatic deficiencies: exploring alterations in erythrocyte glycolysis as an antimalarial strategy. | 000 | 1 | NIH | 7/7/2025 | $187,056 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | K08HL177281 | Dysregulation of transcription factors and chromatin architecture in Trisomy 21 hematopoietic disorders | 000 | 1 | NIH | 8/13/2025 | $158,976 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01HL160748 | Preserving Genome Integrity In AAV-Mediated Gene Therapy | 001 | 4 | NIH | 8/14/2025 | $64,523 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | U54DE035976 | Advancing Craniosynostosis Treatment (ACT)Rare Diseases Consortium | 000 | 1 | NIH | 8/19/2025 | $800,000 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | U54DE035976 | Advancing Craniosynostosis Treatment (ACT)Rare Diseases Consortium | 000 | 1 | NIH | 8/19/2025 | $200,000 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01HD117422 | Pediatric Acute Respiratory distress syndrome MAnagement (PARMA) | 000 | 1 | NIH | 8/15/2025 | $767,069 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | U54DE035976 | Advancing Craniosynostosis Treatment (ACT)Rare Diseases Consortium | 002 | 1 | NIH | 9/17/2025 | $0 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | U54DE035976 | Advancing Craniosynostosis Treatment (ACT)Rare Diseases Consortium | 002 | 1 | NIH | 9/17/2025 | $0 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R21HD120719 | Natural History Study and Identification of Patient-Centric Clinical Outcome Assessments in TUBB4A-LD (NIH R21) | 000 | 1 | NIH | 8/29/2025 | $415,245 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | U54DE035976 | Advancing Craniosynostosis Treatment (ACT)Rare Diseases Consortium | 002 | 1 | NIH | 9/17/2025 | $0 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | U54DE035976 | Advancing Craniosynostosis Treatment (ACT)Rare Diseases Consortium | 001 | 1 | NIH | 8/29/2025 | $530,000 |
| | 2025 | 2025 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | U54DE035976 | Advancing Craniosynostosis Treatment (ACT)Rare Diseases Consortium | 001 | 1 | NIH | 8/29/2025 | -$530,000 |
|
